Review



primary antibodies tert  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Novus Biologicals primary antibodies tert
    Primary Antibodies Tert, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies tert/product/Novus Biologicals
    Average 93 stars, based on 33 article reviews
    primary antibodies tert - by Bioz Stars, 2026-06
    93/100 stars

    Images



    Similar Products

    94
    Bioss polyclonal primary tert antibody
    Polyclonal Primary Tert Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal primary tert antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    polyclonal primary tert antibody - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology primary antibodies
    Primary Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    primary antibodies - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    Novus Biologicals primary antibodies tert
    Primary Antibodies Tert, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies tert/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    primary antibodies tert - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    Bioss tert polyclonal antibody
    Tert Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tert polyclonal antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    tert polyclonal antibody - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    90
    RayBiotech inc primary antibody tert
    Primary Antibody Tert, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody tert/product/RayBiotech inc
    Average 90 stars, based on 1 article reviews
    primary antibody tert - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary monoclonal antibodies against human tert a-6
    (a) PCR-amplified products of <t>TERT</t> promoter from conjunctival SCC cases (M, DNA size marker). (b) Schematic representation showing the translation (ATG) start site, transcription start site, and known hotspot mutations in TERT promoter (the region highlighted in red) (c) Wild-type chromatogram of the promoter region of TERT from normal skin obtained by Sanger sequencing. (d and e) Sequence chromatograms showing the wild-type sequence. (f and g) The mutations c.-146C>T (C250T; Chr.5: 1295250C>T) and c.-124C>T (C228T; Chr.5:1295228C>T) identified in TERT promoter locus in conjunctival SCC cases
    Primary Monoclonal Antibodies Against Human Tert A 6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary monoclonal antibodies against human tert a-6/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary monoclonal antibodies against human tert a-6 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    93
    Novus Biologicals mouse anti tert primary antibody
    (a) PCR-amplified products of <t>TERT</t> promoter from conjunctival SCC cases (M, DNA size marker). (b) Schematic representation showing the translation (ATG) start site, transcription start site, and known hotspot mutations in TERT promoter (the region highlighted in red) (c) Wild-type chromatogram of the promoter region of TERT from normal skin obtained by Sanger sequencing. (d and e) Sequence chromatograms showing the wild-type sequence. (f and g) The mutations c.-146C>T (C250T; Chr.5: 1295250C>T) and c.-124C>T (C228T; Chr.5:1295228C>T) identified in TERT promoter locus in conjunctival SCC cases
    Mouse Anti Tert Primary Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti tert primary antibody/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    mouse anti tert primary antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    (a) PCR-amplified products of TERT promoter from conjunctival SCC cases (M, DNA size marker). (b) Schematic representation showing the translation (ATG) start site, transcription start site, and known hotspot mutations in TERT promoter (the region highlighted in red) (c) Wild-type chromatogram of the promoter region of TERT from normal skin obtained by Sanger sequencing. (d and e) Sequence chromatograms showing the wild-type sequence. (f and g) The mutations c.-146C>T (C250T; Chr.5: 1295250C>T) and c.-124C>T (C228T; Chr.5:1295228C>T) identified in TERT promoter locus in conjunctival SCC cases

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: (a) PCR-amplified products of TERT promoter from conjunctival SCC cases (M, DNA size marker). (b) Schematic representation showing the translation (ATG) start site, transcription start site, and known hotspot mutations in TERT promoter (the region highlighted in red) (c) Wild-type chromatogram of the promoter region of TERT from normal skin obtained by Sanger sequencing. (d and e) Sequence chromatograms showing the wild-type sequence. (f and g) The mutations c.-146C>T (C250T; Chr.5: 1295250C>T) and c.-124C>T (C228T; Chr.5:1295228C>T) identified in TERT promoter locus in conjunctival SCC cases

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Amplification, Marker, Sequencing

    Immunohistochemistry scoring

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: Immunohistochemistry scoring

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Immunohistochemistry, Staining

    (a) Strong cytoplasmic positivity of TERT in a case of conjunctival squamous cell carcinoma. (b) Positive control showing cytoplasmic positivity of TERT in a case of conjunctival melanoma tissue (c) Negative control; primary antibody replaced by TBS. (d) low expression of TERT in skin eyelid

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: (a) Strong cytoplasmic positivity of TERT in a case of conjunctival squamous cell carcinoma. (b) Positive control showing cytoplasmic positivity of TERT in a case of conjunctival melanoma tissue (c) Negative control; primary antibody replaced by TBS. (d) low expression of TERT in skin eyelid

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Positive Control, Negative Control, Expressing

     TERT  immunohistochemical expression and association with clinicopathologic features and  TERT  promoter mutation in ocular surface squamous cell carcinoma

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: TERT immunohistochemical expression and association with clinicopathologic features and TERT promoter mutation in ocular surface squamous cell carcinoma

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Immunohistochemical staining, Expressing, Mutagenesis

    Kaplan–Meier analysis showing reduced disease-free survival rates in conjunctival squamous cell carcinoma in patients with positive TERT expression

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: Kaplan–Meier analysis showing reduced disease-free survival rates in conjunctival squamous cell carcinoma in patients with positive TERT expression

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Expressing

     TERT  promoter mutation and association with clinicopathological features in ocular surface squamous cell carcinoma

    Journal: Indian Journal of Ophthalmology

    Article Title: Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma

    doi: 10.4103/ijo.IJO_1342_21

    Figure Lengend Snippet: TERT promoter mutation and association with clinicopathological features in ocular surface squamous cell carcinoma

    Article Snippet: After cooling, the slides were washed using TBS (pH 7.5) and then incubated for 20 min with 0.3%-v/v H 2 O 2 , followed by incubation with primary monoclonal antibodies against human TERT (A-6, SCBT, Santa Cruz, CA, USA) at a dilution of 1:50 and were processed using the UltravisionQuanto detection system (Thermo Scientific, Fermont CA, USA).

    Techniques: Mutagenesis